image
Healthcare - Biotechnology - NASDAQ - US
$ 4.52
1.35 %
$ 33 M
Market Cap
-0.42
P/E
Price Target Average
193.14%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
21.12%
Net Income Estimate
--51.34%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Kezar Life Sciences, Inc.
image
Wall Street analysts predict an average 1-year price target for KZR of $13.2 , with forecasts ranging from a low of $9 to a high of $21 .
KZR Lowest Price Target Wall Street Target
9 USD 99.12%
KZR Average Price Target Wall Street Target
13.2 USD 193.14%
KZR Highest Price Target Wall Street Target
21 USD 364.60%
Price
Max Price Target
Min Price Target
Average Price Target
8080707060605050404030302020101000Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26
REVENUE FORECAST

Revenue Forecast Chart KZR

image
$35.0m$35.0m$30.0m$30.0m$25.0m$25.0m$20.0m$20.0m$15.0m$15.0m$10.0m$10.0m$5.0m$5.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart KZR

image
$20.0m$20.0m$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart KZR

image
$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)($600.0m)($600.0m)($700.0m)($700.0m)($800.0m)($800.0m)($900.0m)($900.0m)($1.0b)($1.0b)20232023202420242025202520262026202720272028202820292029